These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
269 related articles for article (PubMed ID: 29126547)
1. Microvolt T-wave alternans monitoring in a patient with levofloxacin-induced Torsade de Pointes. Sahashi Y; Takasugi N; Naruse G; Kubota T; Nishigaki K; Minatoguchi S J Electrocardiol; 2018; 51(1):108-110. PubMed ID: 29126547 [TBL] [Abstract][Full Text] [Related]
2. Prevalence of Microvolt T-Wave Alternans in Patients With Long QT Syndrome and Its Association With Torsade de Pointes. Takasugi N; Goto H; Takasugi M; Verrier RL; Kuwahara T; Kubota T; Toyoshi H; Nakashima T; Kawasaki M; Nishigaki K; Minatoguchi S Circ Arrhythm Electrophysiol; 2016 Feb; 9(2):e003206. PubMed ID: 26839386 [TBL] [Abstract][Full Text] [Related]
3. Clarithromycin induced torsade de pointes. Hensey C; Keane D Ir J Med Sci; 2008 Mar; 177(1):67-8. PubMed ID: 17618400 [TBL] [Abstract][Full Text] [Related]
4. Concomitant use of levofloxacin and fluconazole leading to possible torsades de pointes. Tilton JJ; Sadr R; Groo VL J Oncol Pharm Pract; 2019 Dec; 25(8):2004-2006. PubMed ID: 30501378 [TBL] [Abstract][Full Text] [Related]
5. Torsade de pointes induced by terfenadine in a patient with long QT syndrome. Koh KK; Rim MS; Yoon J; Kim SS J Electrocardiol; 1994 Oct; 27(4):343-6. PubMed ID: 7815014 [TBL] [Abstract][Full Text] [Related]
6. Long QT Syndrome and Torsade de Pointes Ultimately Treated With Quinidine: Introducing the Concept of Pseudo-Torsade de Pointes. Viskin S; Marai I; Rosso R Circulation; 2021 Jul; 144(1):85-89. PubMed ID: 34228481 [No Abstract] [Full Text] [Related]
7. Amiodarone-associated macroscopic T-wave alternans and torsade de pointes unmasking the inherited long QT syndrome. Wegener FT; Ehrlich JR; Hohnloser SH Europace; 2008 Jan; 10(1):112-3. PubMed ID: 18006559 [No Abstract] [Full Text] [Related]
8. Risk screening for long QT prior to prescribing levofloxacin. Tsai LH; Weng YM; Lin CC; Kuo CW; Chen JC Am J Emerg Med; 2014 Sep; 32(9):1153.e1-3. PubMed ID: 24666739 [No Abstract] [Full Text] [Related]
9. [QT prolongation and torsade de pointes tachycardia during therapy with maprotiline. Differential diagnostic and therapeutic aspects]. Lentini S; Rao ML; Schröder R; Lüderitz B; Bauriedel G Dtsch Med Wochenschr; 2001 Dec; 126(49):1396-400. PubMed ID: 11740632 [TBL] [Abstract][Full Text] [Related]
10. Torsade de pointes and prolonged QT interval from surreptitious use of sotalol: use of drug levels in diagnosis. Link MS; Foote CB; Sloan SB; Homoud MK; Wang PJ; Estes NA Chest; 1997 Aug; 112(2):556-7. PubMed ID: 9266902 [TBL] [Abstract][Full Text] [Related]
12. QT interval prolongation and torsade de pointes. Patanè S; Marte F; Di Bella G Int J Cardiol; 2009 Jan; 131(2):e51-3. PubMed ID: 17689729 [TBL] [Abstract][Full Text] [Related]
13. [Torsade de pointes and QT syndrome]. Haverkamp W; Hördt M; Borggrefe M; Breithardt G Med Klin (Munich); 1995 Apr; 90(4):240-5. PubMed ID: 7776938 [No Abstract] [Full Text] [Related]
14. QT interval prolongation, torsade de pointes and renal disease. Patanè S; Marte F; Di Bella G; Currò A; Coglitore S Int J Cardiol; 2008 Nov; 130(2):e71-3. PubMed ID: 18255176 [TBL] [Abstract][Full Text] [Related]
15. Moxifloxacin and torsade de pointes. Dale KM; Lertsburapa K; Kluger J; White CM Ann Pharmacother; 2007 Feb; 41(2):336-40. PubMed ID: 17284508 [TBL] [Abstract][Full Text] [Related]